Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06607185
What this trial is testing

The Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerColorectal Cancer+2 more
Eli Lilly and Company 750
Testing effectiveness (Phase 2)Looking for participantsNCT06333314
What this trial is testing

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

Who this might be right for
Pancreatic AdenocarcinomaAmpulla of Vater CarcinomaAdrenocortical Carcinoma+5 more
UNICANCER 120
Early research (Phase 1)Looking for participantsNCT05372614
What this trial is testing

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8+3 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Study completedNCT00630552
What this trial is testing

QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasMetastatic Pancreatic CancerPancreatic Cancer
NantCell, Inc. 138
Testing effectiveness (Phase 2)Study completedNCT00366457
What this trial is testing

Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdenocarcinoma of the Pancreas
Massachusetts General Hospital 32
Post-approval studies (Phase 4)WithdrawnNCT02570529
What this trial is testing

Prevention of Upper Gastrointestinal Hemorrhage Using Albis® in the Patients of Locally Advanced Pancreatic Cancer Who Underwent Concurrent Chemoradiotherapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Yonsei University
Not applicableStudy completedNCT01236053
What this trial is testing

Cancer in Patients With Gabapentin (GPRD)

Who this might be right for
Pain, NeuropathicEpilepsyRenal Pelvis Cancer+13 more
GlaxoSmithKline 2,323,608
Not applicableStudy completedNCT05078775
What this trial is testing

Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma
Faeth Therapeutics 39
Testing effectiveness (Phase 2)Study completedNCT00078975
What this trial is testing

3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University Health Network, Toronto 26
Early research (Phase 1)Study completedNCT00885066
What this trial is testing

Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Centre Antoine Lacassagne 30
Testing effectiveness (Phase 2)UnknownNCT06472037
What this trial is testing

AG Combined With Cadonilimab Sequential Short-course Radiotherapy in the Treatment of Locally aPDAC

Who this might be right for
Locally Advanced Pancreatic Ductal Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableLooking for participantsNCT06655233
What this trial is testing

Profiling the Intratumoral Microbiome of Pancreatic Ductal Adenocarcinoma Based on EUS-FNB Tissue Samples and Exploring Its Impact on Tumor Diagnosis and Prognosis.

Who this might be right for
Pancreatic CancerEUS-FNBIntratumoral Microbiota+2 more
The Third Xiangya Hospital of Central South University 50
Testing effectiveness (Phase 2)Study completedNCT01280058
What this trial is testing

Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Acinar Cell CarcinomaPancreatic Ductal AdenocarcinomaRecurrent Pancreatic Carcinoma+1 more
National Cancer Institute (NCI) 73
Not applicableStudy completedNCT01138124
What this trial is testing

Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)

Who this might be right for
Renal Pelvis CancerRestless Legs SyndromeEpilepsy+7 more
GlaxoSmithKline 54,202
Testing effectiveness (Phase 2)Active Not RecruitingNCT07026279
What this trial is testing

Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Metastatic
Amplia Therapeutics Limited 67
Not applicableNot Yet RecruitingNCT07034703
What this trial is testing

Prospective Cohort of Patients Treated Using Neoadjuvant Modified FOLFIRINOX 6 Cycles for Potentially Resectable Pancreatic Duct Adenocarcinoma, Candidate for Participation in the PANACHE02 Clinical Trial

Who this might be right for
Resectable Pancreatic Duct Adenocarcinoma
University Hospital, Rouen 820
Not applicableStudy completedNCT02208024
What this trial is testing

Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body

Who this might be right for
Pancreatic Cancer
University of Cincinnati 18
Testing effectiveness (Phase 2)Study completedNCT00660270
What this trial is testing

Chemotherapy and Radiation Following Pancreatic Surgery

Who this might be right for
Pancreatic Cancer
Washington University School of Medicine 53
Testing effectiveness (Phase 2)Study completedNCT00313560
What this trial is testing

ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA)

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Early research (Phase 1)Ended earlyNCT05977322
What this trial is testing

A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

Who this might be right for
Pancreatic Ductal AdenocarcinomaGastroesophageal AdenocarcinomaGlioblastoma Multiforme
Novartis Pharmaceuticals 24
Next Page